Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Egerton

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Molecular Psychiatry|April 22, 2018
Determinants of treatment response in first-episode psychosis: an <sup>18</sup>F-DOPA PET studySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
Schizophrenia Bulletin|April 3, 2024
Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for PsychosisNicholas R Livingston, Andrea De Micheli, Robert A McCutcheon, et al.
Biological Psychiatry|July 20, 2010
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosisJames M Stone, Oliver D Howes, Alice Egerton, et al.
Schizophrenia Bulletin|December 20, 2015
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-ResponsiveElias Mouchlianitis, Michael A P Bloomfield, Vincent Law, et al.
Biological Psychiatry|August 21, 2018
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography StudySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
EJNMMI Research|December 3, 2020
Evaluation of [<sup>13</sup>N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brainAlice Egerton, Joel T Dunn, Nisha Singh, et al.
Schizophrenia Research|March 5, 2021
Peripheral immune markers and antipsychotic non-response in psychosisDaniela Enache, Naghmeh Nikkheslat, Dina Fathalla, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 13, 2020
The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging StudyRobert A McCutcheon, Sameer Jauhar, Fiona Pepper, et al.
Schizophrenia (Heidelberg, Germany)|December 23, 2024
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flowJunyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
Psychopharmacology|December 2, 2019
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophreniaGrant McQueen, Aderlee Lay, John Lally, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Molecular Psychiatry|April 22, 2018
Determinants of treatment response in first-episode psychosis: an <sup>18</sup>F-DOPA PET studySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
Schizophrenia Bulletin|April 3, 2024
Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for PsychosisNicholas R Livingston, Andrea De Micheli, Robert A McCutcheon, et al.
Biological Psychiatry|July 20, 2010
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosisJames M Stone, Oliver D Howes, Alice Egerton, et al.
Schizophrenia Bulletin|December 20, 2015
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-ResponsiveElias Mouchlianitis, Michael A P Bloomfield, Vincent Law, et al.
Biological Psychiatry|August 21, 2018
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography StudySameer Jauhar, Mattia Veronese, Matthew M Nour, et al.
EJNMMI Research|December 3, 2020
Evaluation of [<sup>13</sup>N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brainAlice Egerton, Joel T Dunn, Nisha Singh, et al.
Schizophrenia Research|March 5, 2021
Peripheral immune markers and antipsychotic non-response in psychosisDaniela Enache, Naghmeh Nikkheslat, Dina Fathalla, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 13, 2020
The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging StudyRobert A McCutcheon, Sameer Jauhar, Fiona Pepper, et al.
Schizophrenia (Heidelberg, Germany)|December 23, 2024
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flowJunyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
Psychopharmacology|December 2, 2019
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophreniaGrant McQueen, Aderlee Lay, John Lally, et al.
Pageof 10